OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Organization: University College London

2 Projects | 2 Researchers | $897,986 Invested

2024

University College London

Simon Mead, MD, FRCP, PhD

Biomarker-driven phenotyping for Alzheimer's disease and related dementia

  • Funding Amount: $297,986
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: Other
  • Status: Active

2020

University College London

Fiona Ducotterd, PhD

Restoration of healthy Wnt signalling in the neurovascular unit through inhibition of Notum carboxylesterase activity: a Lead to Preclinical Candidate Program for Alzheimer’s disease.

  • Funding Amount: $600,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Vascular
  • Status: Closed